Langerhans' cell histiocytosis (Histiocytosis X, Eosinophilic granulomatosis): Difference between revisions
Ttenbergen (talk | contribs) mNo edit summary |
Ttenbergen (talk | contribs) mNo edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
See [[Malignancy (clonal disorder) of blood or lymphoid tissue, NOS]] instead. | |||
{{ICD10 dx | {{ICD10 dx | ||
|ICD10 Code=D76.0 | |ICD10 Code=D76.0 | ||
|StopDate=2020/10/27 | |StopDate=2020/10/27 | ||
}} | }} | ||
== Additional Info == | == Additional Info == | ||
Line 9: | Line 10: | ||
*Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease. | *Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease. | ||
*Eosinophilic granuloma, also known as pulmonary histiocytosis X (PHX) or pulmonary Langerhans cell histiocytosis X (PLCH), is an uncommon interstitial lung disease that is epidemiologically related to tobacco smoking | *Eosinophilic granuloma, also known as pulmonary histiocytosis X (PHX) or pulmonary Langerhans cell histiocytosis X (PLCH), is an uncommon interstitial lung disease that is epidemiologically related to tobacco smoking | ||
=== Legacy === | |||
* this dx was included in error | |||
* existing records in CFE have been changed to [[Malignancy (clonal disorder) of blood or lymphoid tissue, NOS]] (C96) instead | |||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == |